Literature DB >> 2453224

Relationships between glutamate and monoamine metabolites in cerebrospinal fluid and serum in healthy volunteers.

G Alfredsson1, F A Wiesel, A Tylec.   

Abstract

The concentrations of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), 4-hydroxy-3-methoxyphenylglycol (HMPG), and glutamate were determined in cerebrospinal fluid (CSF) and serum in 10 healthy volunteers. The monoamine metabolites were measured by mass fragmentography and the glutamate by high-performance liquid chromatography. The level of glutamate in CSF was low (0.34 +/- 0.14 nmol/ml) in comparison with previously published values. The concentrations of monoamine metabolites in CSF were in close agreement with earlier findings. There were negative correlations between the concentrations of HVA (r = -0.82, p less than 0.01) and 5-HIAA (r = -0.77, p less than 0.01) and glutamate in CSF, but not in serum. The serum levels of HMPG and glutamate were negatively correlated (r = -0.95, p less than 0.001), but not the CSF levels. The HMPG levels in serum and CSF were positively correlated (r = 0.94, p less than 0.001), but not the HVA and the 5-HIAA levels. The serum and CSF levels of glutamate were positively correlated (r = 0.67, p less than 0.05). The results indicate relationships among the metabolism of dopamine, serotonin, and glutamate in the brain and between the metabolism of noradrenaline and glutamate in peripheral tissue.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2453224     DOI: 10.1016/0006-3223(88)90052-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  26 in total

1.  Human cerebrospinal fluid increases the excitability of pyramidal neurons in the in vitro brain slice.

Authors:  Andreas Bjorefeldt; Ulf Andreasson; Jonny Daborg; Ilse Riebe; Pontus Wasling; Henrik Zetterberg; Eric Hanse
Journal:  J Physiol       Date:  2014-11-25       Impact factor: 5.182

2.  The recency ratio is associated with reduced CSF glutamate in late-life depression.

Authors:  Davide Bruno; Jay Nierenberg; Thomas B Cooper; Charles R Marmar; Henrik Zetterberg; Kaj Blennow; Kenji Hashimoto; Nunzio Pomara
Journal:  Neurobiol Learn Mem       Date:  2017-03-18       Impact factor: 2.877

3.  Familial Influences on Mismatch Negativity and Its Association with Plasma Glutamate Level: A Magnetoencephalographic Study in Twins.

Authors:  Yukika Nishimura; Yuki Kawakubo; Motomu Suga; Kenji Hashimoto; Yuichi Takei; Kunio Takei; Hideyuki Inoue; Masato Yumoto; Ryu Takizawa; Kiyoto Kasai
Journal:  Mol Neuropsychiatry       Date:  2016-09-20

4.  Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics.

Authors:  A E Evins; E T Amico; V Shih; D C Goff
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

5.  The relation between peripheral and central glutamate and glutamine in healthy male volunteers.

Authors:  Yanina Shulman; Suzanne Grant; Peter Seres; Chris Hanstock; Glen Baker; Philip Tibbo
Journal:  J Psychiatry Neurosci       Date:  2006-11       Impact factor: 6.186

6.  Serum glutamine, set-shifting ability and anorexia nervosa.

Authors:  Michiko Nakazato; Kenji Hashimoto; Ulrike Schmidt; Kate Tchanturia; Iain C Campbell; David A Collier; Masaomi Iyo; Janet Treasure
Journal:  Ann Gen Psychiatry       Date:  2010-06-25       Impact factor: 3.455

7.  An open clinical and biochemical study of ritanserin in acute patients with schizophrenia.

Authors:  F A Wiesel; A L Nordström; L Farde; B Eriksson
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

8.  Relationships between clinical effects and monoamine metabolites and amino acids in sulpiride-treated schizophrenic patients.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Monoamine metabolites and amino acids in serum from schizophrenic patients before and during sulpiride treatment.

Authors:  G Alfredsson; F A Wiesel
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 10.  Blood glutamate scavenging: insight into neuroprotection.

Authors:  Akiva Leibowitz; Matthew Boyko; Yoram Shapira; Alexander Zlotnik
Journal:  Int J Mol Sci       Date:  2012-08-13       Impact factor: 6.208

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.